Key Metrics
CiteScore 

7.1
Impact Factor 

< 5
SNIP 

1.04
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Pharmacology and Experimental Therapeutics
Journal of Pharmacology and Experimental Therapeutics Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1909 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Pharmacology and Experimental Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Pharmacology and Experimental Therapeutics
Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
- 28 Jan 2027
- The Journal of pharmacology and experimental therapeutics
Keeping it acid ceramidase: How adiponectin protects in the glomerulus.
- 27 Jul 2026
- The Journal of pharmacology and experimental therapeutics
Computational pharmacology and in silico clinical trials for the development of drugs from natural products: A review of advances, opportunities, and challenges.
- 14 Jul 2026
- The Journal of pharmacology and experimental therapeutics
Cardiac homing peptide-decorated epigallocatechin gallate-loaded poly(lactic-co-glycolic acid) nanoparticles alleviate acute myocardial infarction.
- 14 Jul 2026
- The Journal of pharmacology and experimental therapeutics
Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model.
- 9 Jul 2026
- The Journal of pharmacology and experimental therapeutics
M1 muscarinic receptor modulation drives sex-specific alterations of Alzheimer's pathophysiology in APPswe/PSEN1ΔE9 mice.
- 9 Jul 2026
- The Journal of pharmacology and experimental therapeutics
Corrigendum to "Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury".
- 28 Jan 2027
- The Journal of pharmacology and experimental therapeutics
Keeping it acid ceramidase: How adiponectin protects in the glomerulus.
- 27 Jul 2026
- The Journal of pharmacology and experimental therapeutics
Computational pharmacology and in silico clinical trials for the development of drugs from natural products: A review of advances, opportunities, and challenges.
- 14 Jul 2026
- The Journal of pharmacology and experimental therapeutics
Cardiac homing peptide-decorated epigallocatechin gallate-loaded poly(lactic-co-glycolic acid) nanoparticles alleviate acute myocardial infarction.
- 14 Jul 2026
- The Journal of pharmacology and experimental therapeutics
Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model.
- 9 Jul 2026
- The Journal of pharmacology and experimental therapeutics
M1 muscarinic receptor modulation drives sex-specific alterations of Alzheimer's pathophysiology in APPswe/PSEN1ΔE9 mice.
- 9 Jul 2026
- The Journal of pharmacology and experimental therapeutics